Sciecure Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCIECURE PHARMA INC, and what generic and branded alternatives to SCIECURE PHARMA INC drugs are available?
SCIECURE PHARMA INC has three approved drugs.
Summary for Sciecure Pharma Inc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Sciecure Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciecure Pharma Inc | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216235-001 | Mar 2, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciecure Pharma Inc | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209293-002 | Jun 12, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciecure Pharma Inc | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209293-003 | Jun 12, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciecure Pharma Inc | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216235-002 | Mar 2, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciecure Pharma Inc | BUDESONIDE | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 209041-001 | Sep 28, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
